Gut–Lung Axis in Focus: Deciphering the Impact of Gut Microbiota on Pulmonary Arterial Hypertension
Journal of Personalized Medicine · 20.12.2023 · 14 (1) · 8
DOI: 10.3390/jpm14010008 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Personalized Medicine, online erschienen am 20.12.2023. Verfasst von Konrad Suswał und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pulmonology, Alergollogy and Oncology, Medical University of Lublin, 20-954 Lublin, Poland. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 76 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Polish Society of Cardiology.
Abstract (Originalsprache)
Recent advancements in the understanding of pulmonary arterial hypertension (PAH) have highlighted the significant role of the gut microbiota (GM) in its pathogenesis. This comprehensive review delves into the intricate relationship between the GM and PAH, emphasizing the influence of gut microbial composition and the critical metabolites produced. We particularly focus on the dynamic interaction between the gut and lung, examining how microbial dysbiosis contributes to PAH development through inflammation, altered immune responses, and changes in the gut–lung axis. Noteworthy findings include variations in the ratios of key bacterial groups such as Firmicutes and Bacteroidetes in PAH and the pivotal roles of metabolites like trimethylamine N-oxide (TMAO), short-chain fatty acids (SCFAs), and serotonin in the disease’s progression. Additionally, the review elucidates potential diagnostic biomarkers and novel therapeutic approaches, including the use of probiotics and fecal microbiota transplantation, which leverage the gut microbiota for managing PAH. This review encapsulates the current state of research in this field, offering insights into the potential of gut microbiota modulation as a promising strategy in PAH diagnosing and treatment.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pulmonology, Alergollogy and Oncology, Medical University of Lublin, 20-954 Lublin, Poland.
- Department of Cardiology, Medical University of Lublin, 20-954 Lublin, Poland.
- Cardiology Student Scientific Circle, Academy of Silesia, 40-555 Katowice, Poland.
- Primary Care Clinic, Non-Public Healthcare Facility "Medycyna 2001", 20-470 Lublin, Poland.
- Department of Psychiatry, Psychotheraphy and Early Intervention, Medical University of Lublin, 20-954 Lublin, Poland.
ORCID-Profile: Michał Tomaszewski, Agnieszka Styczeń
Förderung
- Polish Society of Cardiology
Zitieren
APA
Suswał, K., Tomaszewski, M., Romaniuk, A., Świechowska-Starek, P., Zygmunt, W., Styczeń, A., & Romaniuk-Suswał, M. (2023). Gut–Lung Axis in Focus: Deciphering the Impact of Gut Microbiota on Pulmonary Arterial Hypertension. Journal of Personalized Medicine, 14(1), 8. https://doi.org/10.3390/jpm14010008
Vancouver
Suswał K, Tomaszewski M, Romaniuk A, Świechowska-Starek P, Zygmunt W, Styczeń A, et al. Gut–Lung Axis in Focus: Deciphering the Impact of Gut Microbiota on Pulmonary Arterial Hypertension. Journal of Personalized Medicine. 2023;14(1):8. doi:10.3390/jpm14010008
BibTeX
@article{Suswa2023,
author = {Suswał, Konrad and Tomaszewski, Michał and Romaniuk, Aleksandra and Świechowska-Starek, Paulina and Zygmunt, Wojciech and Styczeń, Agnieszka and Romaniuk-Suswał, Małgorzata},
title = {Gut–Lung Axis in Focus: Deciphering the Impact of Gut Microbiota on Pulmonary Arterial Hypertension},
journal = {Journal of Personalized Medicine},
year = {2023},
volume = {14},
number = {1},
pages = {8},
doi = {10.3390/jpm14010008}
}
EUVIMED